Overview

Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia

Status:
Completed
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy (defined as complete clinical response at 6 months) of imiquimod vs. standard treatment (surgery) for vulvar intraepithelial neoplasia (VIN).
Phase:
Phase 3
Details
Lead Sponsor:
Medical University of Graz
Collaborator:
Austrian Science Fund (FWF)
Treatments:
Imiquimod